Literature DB >> 10360776

Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal.

J E Greenlee1, J Dalmau, T Lyons, S Clawson, R H Smith, H R Pirch.   

Abstract

Anti-Yo (type I) autoantibodies reactive with Purkinje cell cytoplasmic antigens of 34 and 62 kd are found in the serum and cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration associated with cancer of the ovary, uterus, adnexa, or breast. Anti-Yo antibody response is rarely associated with other tumors. Here, we present a patient who developed paraneoplastic cerebellar degeneration and anti-Yo antibody response in association with transitional cell carcinoma of the bladder. The presence of anti-Yo antibodies was confirmed by immunofluorescence assay and by Western blot analysis against both Purkinje cell lysates and the CDR62 fusion protein. Yo antigen was demonstrated in sections of the patient's tumor. Antibody titers fell after tumor removal. Transitional cell carcinoma should be considered in patients presenting with subacute cerebellar degeneration and anti-Yo antibody response in whom ovarian, adnexal, uterine, or breast cancer cannot be detected.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360776     DOI: 10.1002/1531-8249(199906)45:6<805::aid-ana18>3.0.co;2-g

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

1.  Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab.

Authors:  M Hardy-Werbin; O Arpí; A Taus; P Rocha; D Joseph-Pietras; L Nolan; S Danson; R Griffiths; M Lopez-Botet; A Rovira; J Albanell; C H Ottensmeier; E Arriola
Journal:  Oncoimmunology       Date:  2017-11-27       Impact factor: 8.110

2.  Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review.

Authors:  Macarena Villagrán-García; Sergio Muñiz-Castrillo; Nicolás Lundahl Ciano-Petersen; Alberto Vogrig; Antonio Farina; Marine Villard; Dimitri Psimaras; Agusti Alentorn; David Gonçalves; Nicole Fabien; Véronique Rogemond; Bastien Joubert; Jérôme Honnorat
Journal:  J Neurol       Date:  2022-09-01       Impact factor: 6.682

3.  Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique.

Authors:  S E Monstad; A Storstein; A Dørum; A Knudsen; P E Lønning; H B Salvesen; J H Aarseth; C A Vedeler
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

4.  Paraneoplastic production of heparin-like anticoagulant in a patient with metastatic transitional cell carcinoma.

Authors:  Kelly N Fahl; Stephen A Poon; Ketan K Badani; Mitchell C Benson
Journal:  Can Urol Assoc J       Date:  2009-10       Impact factor: 1.862

5.  Acute motor axonal neuropathy associated with anal carcinoma: Paraneoplastic neurological syndrome or coincidence?

Authors:  José Luis López; Salvador Amezcua; Jordi Pascual; Manuel Algara
Journal:  Rep Pract Oncol Radiother       Date:  2011-02-01

Review 6.  'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook.

Authors:  S Jarius; B Wildemann
Journal:  J Neuroinflammation       Date:  2015-09-17       Impact factor: 8.322

Review 7.  An uncommon manifestation of paraneoplastic cerebellar degeneration in a patient with high grade urothelial, carcinoma with squamous differentiation: A case report and literature review.

Authors:  Yaofeng Zhu; Shouzhen Chen; Songyu Chen; Jing Song; Fan Chen; Hu Guo; Zhenhua Shang; Yong Wang; Changkuo Zhou; Benkang Shi
Journal:  BMC Cancer       Date:  2016-05-21       Impact factor: 4.430

Review 8.  Safety of targeting tumor endothelial cell antigens.

Authors:  Samuel C Wagner; Neil H Riordan; Thomas E Ichim; Julia Szymanski; Hong Ma; Jesus A Perez; Javier Lopez; Juan J Plata-Munoz; Francisco Silva; Amit N Patel; Santosh Kesari
Journal:  J Transl Med       Date:  2016-04-12       Impact factor: 5.531

9.  Treatment of paraneoplastic cerebellar degeneration.

Authors:  John E Greenlee
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

Review 10.  Paraneoplastic and Other Autoimmune Encephalitides: Antineuronal Antibodies, T Lymphocytes, and Questions of Pathogenesis.

Authors:  John E Greenlee; Noel G Carlson; Justin R Abbatemarco; Ida Herdlevær; Stacey L Clardy; Christian A Vedeler
Journal:  Front Neurol       Date:  2022-01-17       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.